Virus, vaccines, testing, and treatments

Two years after the start of the pandemic, many questions about SARS-CoV-2: its characteristics, what tests are available, how to best treat those infected with it, how well the vaccines work, and how the virus is likely to evolve, remain unanswered. In this session we will discuss what is known, what is still controversial, and what are the open questions about the virus.

AGENDA

Roundtable discussion with:

• Zeger Debyser.

• Bernard Rentier.

• Liliane Schoofs.

• Kristien Van Reeth.

SPEAKERS

• Prof. Zeger Debyser, virology, KU Leuven. https://www.kuleuven.be/wieiswie/en/person/00003374

• Prof. Bernard Rentier, virology, ULiège. https://www.uliege.be/cms/c_9054334/fr/repertoire?uid=U010972

• Prof. Liliane Schoofs, molecular biology / immunological biotechnology, KU Leuven. https://www.kuleuven.be/wieiswie/en/person/00009494

• Prof. Kristien Van Reeth, virology, UGent. https://biblio.ugent.be/person/801000914281